Home  »  Business   »  Is Mereo BioPharma Group plc (NASDAQ: MREO) A Grea...

Is Mereo BioPharma Group plc (NASDAQ: MREO) A Great Stock To Invest In?

Mereo BioPharma Group plc (NASDAQ:MREO) traded at $1.02 at close of the session on Monday, 01/23/23, made an upward move of 5.15% on its previous day’s price.

Looking at the stock we see that its previous close was $0.97 and the beta (5Y monthly) reads 0.79 with the day’s price range being $0.902 – $1.17. The company has a trailing 12-month PE ratio of 9.27. In terms of its 52-week price range, MREO has a high of $1.85 and a low of $0.30. The company’s stock has gained about 92.45% over that past 30 days.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Mereo BioPharma Group plc has a market cap of $127.49 million.

There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the MREO stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of Hold.

Based on estimates by 4 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Mereo BioPharma Group plc (MREO) stock as a Hold, while 4 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.

Looking further, we note the current price level is 33.68% off its SMA20 and 33.91% from its 50-day simple moving average. The RSI (14) is pointing at 66.97 while the volatility over the past week is 19.10% and jumps to 17.01% over the past one month. The average price target for the stock over the next 12 months is $4.25, with the estimates having a low of $4.00 and a high of $5.00. These price ends are -292.16% and -390.2% off the current price level respectively, although investors could be excited at the prospect of a -292.16% if the MREO share price touches on the median price of $4.00.

Coming back to Mereo BioPharma Group plc (NASDAQ:MREO), we note that the average 3-month trading volume was 641.87K, while that of the preceding 10-day period stands at 0.78 million. Current shares outstanding are 124.99 million.

The institutions hold 56.82%. The data shows that short shares as of Oct 13, 2022, stood at 6.09 million at a short ratio of 14.16. This represents a 5.21% short interest in shares outstanding on Oct 13, 2022. Shares short fall in October from the previous month at 6.75 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 36.00% up in year-to-date price movement.

Leave a Comment

Your email address will not be published. Required fields are marked *